Purchase Order W81K0219P0236
Award Date 10/1/19
Potential Completion Date 9/30/24
Potential Value $1M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
LEWIS MCCHORD, WA 98431, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for $205,240.00 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is a firm fixed-price purchase order awarded by the Defense Health Agency, a defense agency under the Department of Defense, to provide automated immunohistochemistry (IHC) slide staining platforms, antibody stains, reagents, and supplies to support the Anatomic Pathology mission at Madigan Army...
- The Defense Health Agency awarded a $6.1 million firm fixed-price purchase order to Roche Diagnostics Corporation on October 1, 2021, for advanced histology staining services including immunohistochemistry, in-situ hybridization, and immunofluorescence testing. The contract supports Brooke Army Medical Center at Joint Base San Antonio Fort Sam Houston in Texas and operates on a cost-per-test model with an ultimate completion date of September 30, 2026. No set-aside designation was used in this...
- The Defense Health Agency issued a purchase order to Roche Diagnostics Corporation for the lease of automated slide staining platforms and supplies to support the Anatomic Pathology mission at Madigan Army Medical Center, valued at $276,945.12, awarded October 1, 2021. Performance occurs at Lewis McChord, Washington. The order procures two automated slide staining platforms capable of staining 40 slides per batch with individual temperature control and onboard dewaxing, together with reagents,...
- The Defense Health Agency issued a delivery order to Roche Diagnostics Corporation on October 1, 2025, for an immunohistochemistry and in-situ hybridization automated platform with a ceiling value of $297,929.17. This is a firm fixed-price delivery order issued under a parent Defense Health Agency indefinite delivery contract for immunohistochemistry and in-situ hybridization platforms valued at $1.5 million through September 2030. Place of performance is Joint Base Lewis-McChord, Washington....
- This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The $262,962.36 contract is for the supply of reagents and consumables to support the government-owned Roche b221 blood gas analyzers at Madigan Army Medical Center, Joint Base Lewis-McChord in Washington. The contract has a period of performance through September 30, 2025. This...
- This is a firm-fixed-price delivery order contract awarded by the Defense Health Agency to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $712,750 contract is for immunohistochemical testing services with a performance period through September 30, 2024. Roche Diagnostics has previously received numerous federal contract awards, including through Indefinite Delivery Contracts and Blanket Purchase Agreements, to provide medical...
- The Defense Health Agency awarded a $69,865.08 firm fixed-price purchase order to Roche Diagnostics Corporation for H and E stainer and reagents machinery, with performance at Fort Moore, Georgia and an ultimate completion date of September 30, 2026. This contract was awarded without set-aside designation, reflecting open competition. Roche Diagnostics Corporation, a foreign-owned diagnostic solutions manufacturer headquartered in Indianapolis, Indiana, specializes in in vitro diagnostics,...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $712,750.00, was awarded by the Defense Health Agency (DHA) for "IHC COST PER TEST" services. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) contract vehicle, likely a Blanket Purchase Agreement (BPA) or Indefinite...
- The Defense Health Agency awarded a $678,600 firm-fixed-price purchase order to Roche Diagnostics Corporation for a rapid polymerase chain reaction (PCR) testing analyzer and associated supplies. The contract will support the Department of Pathology at Madigan Army Medical Center in Tacoma, Washington. The analyzer must be able to identify influenza A & B, SARS-CoV-2, respiratory syncytial virus, and streptococcus group A from a patient sample within 20 minutes in a CLIA-waived format....
- This federal contract award was issued by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The $178,187.52 Firm Fixed Price delivery order contract provides immunohistochemistry (IHC) assays, slide stainers, cytology/histology reagents, and other consumables in support of the Naval Medical Center in Portsmouth, Virginia. The contract...